World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
38758
World Ranking
7657
National Ranking
435

Gerd Geisslinger publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gerd Geisslinger sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 642 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gerd Geisslinger D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gerd Geisslinger sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gerd Geisslinger is affiliated with Goethe University Frankfurt in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with 176 and 93 publications respectively. Within these areas, key subfields include Molecular Biology, Physiology, Pharmacology, Immunology, and Rheumatology.

The scientist's work covers a range of topics, notably Pain Mechanisms and Treatments, Sphingolipid Metabolism and Signaling, Eicosanoids and Hypertension Pharmacology, Metabolomics and Mass Spectrometry Studies, SARS-CoV-2 and COVID-19 Research, Pharmacological Effects of Natural Compounds, and Inflammatory mediators and NSAID effects.

Publications by Geisslinger have appeared frequently in several scientific venues. The top publication venues include:

  • International Journal of Molecular Sciences
  • Cells
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Research Square (Research Square)

Notable recent papers highlight diverse areas of research and include:

  • The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2 (2022, Stem Cell Reports)
  • Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far? (2022, Frontiers in Pharmacology)
  • Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen (2021, ACS Pharmacology & Translational Science)
  • Autophagy activation, lipotoxicity and lysosomal membrane permeabilization synergize to promote pimozide- and loperamide-induced glioma cell death (2021, Autophagy)
  • A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection (2021, Scientific Data)

Throughout their career, Geisslinger has collaborated often with several researchers including Robert Gurke, Lisa Hahnefeld, Dominique Thomas, Marco Sisignano, and Sandra Trautmann, with collaboration counts ranging from 20 to 43 publications each.

Best Publications

  • Cyclooxygenase-independent actions of cyclooxygenase inhibitors

    Irmgard Tegeder;Josef Pfeilschifter;Gerd Geisslinger

  • COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib

    Sabine Grösch;Irmgard Tegeder;Ellen Niederberger;Lutz Bräutigam

  • GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence

    Irmgard Tegeder;Michael Costigan;Robert S Griffin;Andrea Abele

  • Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors

    Sabine Grösch;Thorsten Jürgen Maier;Susanne Schiffmann;Gerd Geisslinger

  • Chain length-specific properties of ceramides.

    Sabine Grösch;Susanne Schiffmann;Gerd Geisslinger

  • Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation

    Flora Beiche;Stefan Scheuerer;Kay Brune;Gerd Geisslinger

  • Ziconotide for treatment of severe chronic pain

    Achim Schmidtko;Jörn Lötsch;Rainer Freynhagen;Gerd Geisslinger

  • COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites.

    Maria Burian;Gerd Geisslinger

  • Pharmacokinetics of opioids in liver disease.

    Irmgard Tegeder;Jörn Lötsch;Gerd Geisslinger

  • Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

    Eugen Ruckhäberle;Achim Rody;Knut Engels;Regine Gaetje

  • Genetic predictors of the clinical response to opioid analgesics: Clinical utility and future perspectives

    Jörn Lötsch;Carsten Skarke;Jürgen Liefhold;Gerd Geisslinger

  • Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain

    Marco Sisignano;Ralf Baron;Klaus Scholich;Gerd Geisslinger

  • Ceramide synthases and ceramide levels are increased in breast cancer tissue

    Susanne Schiffmann;Jessica Sandner;Kerstin Birod;Ivonne Wobst

  • Capturing adenylyl cyclases as potential drug targets.

    Sandra Pierre;Thomas Eschenhagen;Gerd Geisslinger;Klaus Scholich

  • Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications

    Irmgard Tegeder;Gerd Geisslinger

  • Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers

    Carsten Skarke;Jutta Darimont;Helmut Schmidt;Gerd Geisslinger

  • The IKK-NF-κB pathway: a source for novel molecular drug targets in pain therapy?

    Ellen Niederberger;Gerd Geisslinger

  • Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.

    Thorsten Jürgen Maier;Karin Schilling;Ronald Schmidt;Gerd Geisslinger

  • Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.

    Harald Dormann;Uta Muth-Selbach;Sabine Krebs;Manfred Criegee-Rieck

  • No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing.

    Achim Schmidtko;Irmgard Tegeder;Gerd Geisslinger

Frequent Co-Authors

Jörn Lötsch
Jörn Lötsch Goethe University Frankfurt
Kay Brune
Kay Brune University of Erlangen-Nuremberg
Gerd Kobal
Gerd Kobal University of Erlangen-Nuremberg
Alfred Ultsch
Alfred Ultsch Philipp University of Marburg
Clifford J. Woolf
Clifford J. Woolf Boston Children's Hospital
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Ralf P. Brandes
Ralf P. Brandes Goethe University Frankfurt
Thomas Hummel
Thomas Hummel TU Dresden
Ingrid Fleming
Ingrid Fleming Goethe University Frankfurt
Domenico Del Turco
Domenico Del Turco Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine involves more than just earning a medical degree. Many students explore related health fields and advanced qualifications that can open doors to new opportunities. Allied degrees such as an online master of health administration help future professionals develop strong leadership and management skills in the healthcare sector.

Affordability is often a top concern for students. There are options for cheapest mha programs that offer quality education without a hefty price tag. For those who wish to advance their clinical expertise, flexible and accredited dnp online programs cheap are also accessible, leading to roles in advanced practice nursing and healthcare leadership.

Pharmacists play a vital role in healthcare delivery. If pharmaceutical studies interest you, consider an online pharmd program for a career in pharmacy with the convenience of distance learning. Each pathway offers diverse options for growth and advancement in the healthcare industry.

Best Scientists Citing Gerd Geisslinger

Trending Scientists

Recently Published Articles